Zacks Research Downgrades Integer (NYSE:ITGR) to Strong Sell

Integer (NYSE:ITGR) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Monday,Zacks.com reports.

A number of other research firms also recently weighed in on ITGR. Raymond James Financial reaffirmed an “outperform” rating and issued a $101.00 price target on shares of Integer in a research note on Monday, February 23rd. Wall Street Zen downgraded shares of Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Citigroup dropped their price target on shares of Integer from $92.00 to $89.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Truist Financial upped their price target on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Finally, Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Four investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $98.29.

Integer Price Performance

NYSE ITGR opened at $85.15 on Monday. The stock has a market capitalization of $2.89 billion, a P/E ratio of 21.23, a P/E/G ratio of 1.47 and a beta of 0.67. Integer has a 1 year low of $62.00 and a 1 year high of $123.78. The business’s fifty day moving average is $86.07 and its two-hundred day moving average is $80.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The firm had revenue of $439.58 million for the quarter, compared to analyst estimates of $426.48 million. During the same period last year, the firm earned $1.31 earnings per share. Integer’s revenue for the quarter was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, research analysts forecast that Integer will post 6.11 earnings per share for the current fiscal year.

Insider Buying and Selling at Integer

In other Integer news, VP Tommy P. Thomas sold 825 shares of the firm’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the completion of the transaction, the vice president owned 4,381 shares in the company, valued at $372,385. This trade represents a 15.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 1.10% of the company’s stock.

Institutional Trading of Integer

Several hedge funds have recently modified their holdings of ITGR. Salomon & Ludwin LLC increased its holdings in shares of Integer by 46.8% in the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 118 shares in the last quarter. Global Retirement Partners LLC increased its holdings in shares of Integer by 293.8% in the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 238 shares in the last quarter. TD Private Client Wealth LLC increased its holdings in shares of Integer by 1,037.5% in the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 415 shares in the last quarter. Parkside Financial Bank & Trust increased its holdings in shares of Integer by 135.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares in the last quarter. Finally, Arax Advisory Partners grew its holdings in Integer by 2,489.5% during the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 473 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.